← Back to Search

Meditation App for Emotion Regulation in Youth on Probation (ProjectAIM Trial)

N/A
Recruiting
Led By Ashley D Kendall, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
13-18 years old
Be younger than 65 years old
Must not have
Are detained
Do not speak English, due to norming of instruments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-month follow-up, 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a mindfulness intervention delivered via smartphone app can help justice-involved youth on probation regulate their emotions and make healthier choices regarding alcohol use, drug use, sex, and aggression.

Who is the study for?
This trial is for justice-involved youth aged 13-18 on probation in Chicago's Cook County. Participants must understand consent procedures, speak English, have a legal guardian's permission if under 18, agree to participate, and own an Apple or Android phone. Those detained or in DCFS care are excluded.
What is being tested?
The study compares two groups: one uses the Bodhi AIM meditation app (intervention group) and the other does not (control group). It aims to see if the app helps with emotion control and reduces risky behaviors related to HIV/STI like alcohol/cannabis use, sexual activity, and aggression.
What are the potential side effects?
Since this trial involves using a meditation app rather than medication, there aren't typical side effects. However, participants may experience discomfort when discussing personal topics or increased awareness of emotions during mindfulness practice.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 13 and 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently detained.
Select...
I do not speak English.
Select...
My legal guardian has not given permission for me to join if I'm under 18.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-month follow-up, 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-month follow-up, 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in Aggression
Changes in Alcohol Use
Changes in Cannabis Use
+2 more
Secondary study objectives
App Usage
Changes in Additional Facets of Aggression
Changes in Alcohol Trouble
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bodhi AIMExperimental Treatment1 Intervention
Participants randomized to the intervention group will receive the Bodhi AIM app
Group II: HIBActive Control1 Intervention
Participants randomized to the health promotion control group will receive the HIB app

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,587 Previous Clinical Trials
3,328,348 Total Patients Enrolled
2 Trials studying Aggression
5,593 Patients Enrolled for Aggression
University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,919 Total Patients Enrolled
Ashley D Kendall, PhDPrincipal InvestigatorUniversity of Illinois at Chicago

Media Library

Bodhi AIM (intervention group) Clinical Trial Eligibility Overview. Trial Name: NCT05146167 — N/A
Aggression Research Study Groups: Bodhi AIM, HIB
Aggression Clinical Trial 2023: Bodhi AIM (intervention group) Highlights & Side Effects. Trial Name: NCT05146167 — N/A
Bodhi AIM (intervention group) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05146167 — N/A
~18 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top